These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25634221)

  • 1. Successful rapid desensitization to intravenous etoposide using a 14-step protocol.
    Garcia Escallon S; Muniyappa PK; Subramanian S
    J Allergy Clin Immunol Pract; 2015; 3(4):627-8. PubMed ID: 25634221
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etoposide desensitization. A case report].
    Alvarez Cardona A; Hernández Nieto L; Pérez Gómez M; Pedroza Meléndez A; Huerta López JG
    Rev Alerg Mex; 2010; 57(1):33-6. PubMed ID: 20857627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-step etoposide desensitization protocol: A pediatric, adolescent, and young adult case series.
    Stockton W; Lam F; Nguyen T; Nguyen T; Kirov I
    Pediatr Blood Cancer; 2021 Jan; 68(1):e28795. PubMed ID: 33155419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient experiences adverse drug reaction to etoposide for adenocarcinoma of the lung.
    Ives RK
    Oncol Nurs Forum; 1995 Sep; 22(8):1289. PubMed ID: 8532560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indirect identification of hypersensitivity reaction to etoposide mediated by polysorbate 80].
    Pantín C; Letellez J; Calzas J; Mohedano E
    Farm Hosp; 2018 Jan; 42(1):27-28. PubMed ID: 29306312
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful Desensitization Protocol for Hypersensitivity Reaction Caused by Irinotecan in a Patient With Metastatic Colorectal Cancer.
    Abu-Amna M; Hassoun G; Hadad S; Haim N; Bar-Sela G
    Clin Colorectal Cancer; 2015 Dec; 14(4):e49-51. PubMed ID: 26051444
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful docetaxel tolerance induction.
    Messaad D; Sablayrolles P; Pujol JL; Demoly P
    Allergy; 2003 Dec; 58(12):1320-1. PubMed ID: 14616116
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypersensitivity reaction to etoposide. A case report].
    Mullera Martí M; Riba Solé M; Fernández de Gamarra Martínez E; Mangues Bafalluy MA
    Farm Hosp; 2014 May; 38(3):255-6. PubMed ID: 24951914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide hypersensitivity.
    Yersal O; Barutca S; Meydan N
    J BUON; 2013; 18(2):547-8. PubMed ID: 23818380
    [No Abstract]   [Full Text] [Related]  

  • 10. A case series of pediatric oncology patients undergoing successful rapid etoposide desensitization.
    Wright TE; Shah MD; Rider NL; Porea TJ; Musick MA; Miller J; Daves M; Foster JH; Anvari S
    Pediatr Allergy Immunol; 2019 Aug; 30(5):579-582. PubMed ID: 30963632
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on: Six-step etoposide desensitization protocol: A pediatric, adolescent, and young adult case series.
    Diebert N; Roh L; Fernández KS
    Pediatr Blood Cancer; 2021 May; 68(5):e28881. PubMed ID: 33381884
    [No Abstract]   [Full Text] [Related]  

  • 12. Paclitaxel hypersensitivity revisited.
    Essayan DM; Kagey-Sobotka A; Lichtenstein LM
    J Clin Oncol; 1996 Mar; 14(3):1042. PubMed ID: 8622009
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypersensitivity reactions to etoposide.
    Hoetelmans RM; Schornagel JH; ten Bokkel Huinink WW; Beijnen JH
    Ann Pharmacother; 1996 Apr; 30(4):367-71. PubMed ID: 8729891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of pertuzumab and docetaxel desensitization in oncological patient; apropos of a case].
    Guerrero Bautista R; Chica Marchal A; García Simón MS; Ferris Villanueva E; Pérez Cañadas P; De Andrés Bautista M
    Farm Hosp; 2014 Nov; 38(6):491-3. PubMed ID: 25542663
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral etoposide-induced leucocytoclastic vasculitis in a patient with lung carcinoma.
    Turken O; Karagoz B; Bilgi O; Doğan B; Kandemir EG; Kunter E
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1297-8. PubMed ID: 17894749
    [No Abstract]   [Full Text] [Related]  

  • 16. Safe and Time-Saving Desensitization Protocol to Intravenous Etoposide.
    Gómez-Duque M; Sala-Cunill A; Farriols A; Cardona V; Luengo O
    J Allergy Clin Immunol Pract; 2016; 4(4):793-4. PubMed ID: 27393789
    [No Abstract]   [Full Text] [Related]  

  • 17. Successful rapid desensitization to intravenous bevacizumab using a 14-step protocol: Case report.
    Williams SJ; Khokhar A; Gharib A
    J Allergy Clin Immunol Pract; 2017; 5(6):1746-1747. PubMed ID: 28606785
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
    Feldweg AM; Lee CW; Matulonis UA; Castells M
    Gynecol Oncol; 2005 Mar; 96(3):824-9. PubMed ID: 15721432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful desensitization of two patients with ALK-positive lung cancer and hypersensitivity to crizotinib.
    Awad MM; Lax TP; Slawski BR; Shaw AT
    J Thorac Oncol; 2014 Nov; 9(11):1726-8. PubMed ID: 25436807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term oral administration of etoposide in the treatment of patients with advanced non-small-cell carcinoma of the lung. The second phase of a clinical study].
    Jeremić B; Djurić Lj; Jevremović S; Stefanović K; Matović M
    Srp Arh Celok Lek; 1996; 124(3-4):65-8. PubMed ID: 9102821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.